Nyxoah SA (NYXH): Price and Financial Metrics

Nyxoah SA (NYXH): $9.30

0.40 (+4.49%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

F

NYXH Price/Volume Stats

Current price $9.30 52-week high $20.00
Prev. close $8.90 52-week low $4.00
Day low $9.00 Volume 66,200
Day high $9.76 Avg. volume 58,621
50-day MA $13.63 Dividend yield N/A
200-day MA $8.41 Market Cap 231.94M

NYXH Stock Price Chart Interactive Chart >


Nyxoah SA (NYXH) Company Bio


Nyxoah S.A., a health-technology company, focuses on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. It offers Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treast moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is based in Mont-Saint-Guibert, Belgium.


NYXH Latest News Stream


Event/Time News Detail
Loading, please wait...

NYXH Latest Social Stream


Loading social stream, please wait...

View Full NYXH Social Stream

Latest NYXH News From Around the Web

Below are the latest news stories about NYXOAH SA that investors may wish to consider to help them evaluate NYXH as an investment opportunity.

Nyxoah Announces Real World Case Series Demonstrating Positive Results in Treating CCC Patients with Genio®

Nyxoah Announces Real World Case Series Demonstrating Positive Results in Treating CCC Patients with Genio® Data presented at the DGSM Conference in Berlin by Dr. Christian Plettenberg on December 8, 2023Results showed an average AHI decrease of 73% Mont-Saint-Guibert, Belgium – December 11, 2023, 7:30am CET / 1:30am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to

Yahoo | December 11, 2023

Publication Relating to a Transparency Notification

REGULATED INFORMATION Publication Relating to a Transparency Notification Mont-Saint-Guibert (Belgium), December 8, 2023, 10.30pm CET / 4.30pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below. On December 6, 2023, Nyxoah received a transparency notification from Deerfield Partners, L.P. indicating that Deerfield Partners, L.P. cr

Yahoo | December 8, 2023

Nyxoah Strengthens its Executive Leadership Team

Nyxoah Strengthens its Executive Leadership TeamFrancis Kim appointed as Chief Regulatory and Quality Officer Mont-Saint-Guibert, Belgium – November 28, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced the appointment of Francis Kim as Chief Regulatory and Quality Officer. Francis will

Yahoo | November 28, 2023

Why Is AgriForce Growing Systems (AGRI) Stock Moving Today?

AgriForce Growing Systems stock is on the move Monday as AGRI investors react to a letter from the company's CEO concerning its performance.

William White on InvestorPlace | November 27, 2023

Why Is Altamira Therapeutics (CYTO) Stock Down 8% Today?

Altamira Therapeutics stock is sliding lower on Monday as investors in CYTO shares react to a delisting notice from the Nasdaq Exchange.

William White on InvestorPlace | November 27, 2023

Read More 'NYXH' Stories Here

NYXH Price Returns

1-mo -52.31%
3-mo 120.90%
6-mo 51.96%
1-year -4.66%
3-year N/A
5-year N/A
YTD 100.43%
2023 -7.01%
2022 -78.30%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!